Lv0
0 积分 2026-03-12 加入
Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo
1个月前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
1个月前
已完结
Targeting DNA damage response pathways in cancer
2个月前
已完结
DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies
2个月前
已完结